Objectives
To determine the kinetics of alkaline phosphatase (AP) activity and concentration after infant cardiopulmonary bypass including isoform-specific changes, and to measure the association between post-operative AP activity and major post-operative cardiovascular events, organ injury/dysfunction, and post-operative support requirements
Study design
Prospective cohort study of 120 infants ≤120 days of age undergoing cardiopulmonary bypass. AP total and isoform-specific activity was assessed at 6 time-points (pre-operation, rewarming, 6, 24, 48, and 72h post-operation). Low AP activity was defined as ≤80U/L. AP concentrations and biomarkers of organ injury/dysfunction were collected through 24h post-operation. Major cardiovascular events were defined as cardiac arrest, mechanical circulatory support, or death.
Results
AP activity loss occurred primarily during the operation (median decrease 89 U/L; P<.0001) secondary to decreased bone and liver 2 isoforms. Activity declined through 24h in 27% of patients. AP activity strongly correlated with serum concentration (r=0.87-0.91; P<.0001).
Persistent low AP activity at 72h was independently associated with occurrence of a major cardiac event (OR 5.6; p<0.05). Early AP activity was independently associated with subsequent vasoactive-inotropic score (p<0.001), peak lactate (p<0.0001), peak creatinine (p<0.0005), NT-proBNP (p<0.05), and intestinal fatty acid binding protein (p<0.005).
Conclusions
AP activity decreases during infant cardiopulmonary bypass and may continue to drop for 24h. Activity loss is secondary to decreased bone and liver 2 isoform concentrations. Early low AP activity is independently associated with subsequent post-operative support and organ injury/dysfunction, and persistence of AP activity ≤80U/L at 72h is independently associated with increased odds of major cardiovascular events.